Oleg from Romania

Registered at the short selling broker NS Broker, 2 minutes ago.

» Try NS Broker you too
54.6% of retail CFD accounts lose money.
Don't show again

Immunovant, Inc. (IMVT) shares information

Immunovant Inc


24h Change

-1.93 %

IMVT

Live rate: Market closed

Stock data per Friday 24 Sep, 2021

IMVT
NASDAQ
8.82
8.78
8.65
-0.17 (-1.93%)
US Market is closed

Live Stock price in graph for Immunovant Inc (IMVT)

  • Latest Volume

    347,048 (-24.09 %)

  • Volume prev. day

    457,196

  • Avg. daily volume

    649,236

  • Market cap

    994,740,234

  • P/E ratio

    n/a

  • Today high

    8.84 USD

  • Today low

    8.61 USD

  • 52 week high

    53.75 USD

  • 52 week low

    6.68 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Immunovant Inc

Below you can find the most recent news posts about Immunovant Inc, primarily from US and UK based news sources.

Immunovant appoints Renee Barnett as CFO

Wednesday, 15 September 2021, 13:37:21
No summary available.
— Seeking Alpha


Immunovant Appoints Renee Barnett as Chief Financial Officer

Wednesday, 15 September 2021, 13:00:00
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced the appointment of Renee Barnett, as Chief Financial Officer, effective October 4, 2021.
— Intrado Digital Media


Immunovant Reports Financial Results for the Quarter Ended June 30, 2021

Monday, 9 August 2021, 12:30:00
Company Ended the Quarter With Cash of Approximately $379 Million and Subsequently Received a Direct Investment of $200 Million from Roivant Company Ended the Quarter With Cash of Approximately $379 Million and Subsequently Received a Direct Investment of $200 Million from Roivant
— Intrado Digital Media


Immunovant to Report Financial Results for Quarter Ended June 30, 2021

Friday, 6 August 2021, 22:22:00
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it will host a conference call and audio webcast on Monday, August 9, 2021 at 8 a.m. ET to discuss financial results for its fiscal first quarter ended June 30, 2021.
— Intrado Digital Media


Why Shares of Immunovant Are Down Almost 10% This Afternoon

Tuesday, 3 August 2021, 21:49:00
An analyst note is extending yesterday”s sell-off.
— The Motley Fool


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have IMVT available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.